Target intelligence / Profile preview

Small proline-rich protein 2A (SPRR2A)

Target
SPRR2A
Molecular classification
Other (antimicrobial protein, cornified envelope precursor protein)
01

Overview

Small proline-rich protein 2A (SPRR2A) is a secreted, cysteine- and proline-rich protein expressed by epithelial cells—including Paneth and goblet cells of the intestine—and is phylogenetically distinct from other known mammalian antimicrobial proteins[1]. It is uniquely upregulated in the gut during type 2 immune responses, such as those induced by helminth infections, and selectively kills Gram-positive bacteria by binding to, and disrupting, their membranes via salt- and pH-dependent interactions with negatively charged membrane lipids[1]. SPRR2A helps shape the intestinal microbiota, restricts bacterial access to the intestinal surface, and prevents tissue invasion by bacteria, particularly during parasite infection[1]. Beyond its role in innate immunity, SPRR2A is overexpressed in several cancers, notably gastric cancer (where it is a promising serum biomarker), and may promote epithelial-mesenchymal transition and cell migration by inhibiting p53 acetylation, which is linked to tumor invasion and metastasis[2].

Other names
SPR-2A2-1small proline-rich protein 2ASPRR2A
02

Biological functions

Antimicrobial activity (bactericidal protein)Barrier protection (intestinal barrier)Cell migrationWound healing
03

Disease associations

Cancer (gastric cancer, head and neck squamous cell carcinoma)Infection (intestinal bacterial infection, helminth infection)Inflammation
04

Biomarkers

Serum SPRR2A as a diagnostic biomarker for gastric cancer[2]Prognostic biomarker for lymph node metastasis and monitoring after gastric cancer surgery[2]

Beyond the preview

Go deeper on Small proline-rich protein 2A (SPRR2A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small proline-rich protein 2A (SPRR2A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call